Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Mayoh

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Cancers|May 23, 2020
Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian ChildrenMarion K Mateos, Morten Tulstrup, Michael Cj Quinn, et al.
Journal of Neuro-Oncology|November 18, 2018
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
International Journal of Cancer|November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Journal of Neuro-Oncology|November 29, 2018
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Cancers|May 23, 2020
Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian ChildrenMarion K Mateos, Morten Tulstrup, Michael Cj Quinn, et al.
Journal of Neuro-Oncology|November 18, 2018
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
International Journal of Cancer|November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
Molecular Systems Biology|October 1, 2025
High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.
Journal of Neuro-Oncology|November 29, 2018
Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaMaria Tsoli, Han Shen, Chelsea Mayoh, et al.
Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.
Nature Communications|May 19, 2026
Precision-guided therapy in H3K27-altered diffuse midline gliomaCampbell J L McKay, Chelsea Mayoh, Phoebe Power, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Communications Biology|October 14, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesisBelamy B Cheung, Ritu Mittra, Jayne Murray, et al.
Pageof 10